Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
These are in vitro and preclinical findings no large randomised controlled trials in humans have been completed for systemic GHK Cu
Soltan-SharifiMSMojtahedzadehMNajafiAKhajaviMRRouiniMRMoradiMet alImprovement by N-acetylcysteine of acute respiratory distress syndrome through increasing intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: evidence for underlying toxicological mechanisms
Complete reversal of advanced pattern baldness
Kharas MG, Lengner CJ
ACL reconstruction (rat model): Intra-articular GHK-Cu injections at 0.3-3 mg/mL transiently improved knee laxity outcomes at 6 weeks post-surgery, though improvements were not sustained at 12 weeks (PMID 25731775)
In 2021, larger trials demonstrated the effectiveness of the drug for both diabetes and weight loss
US$ 27.82
US$ 25.53
US$ 27.10
US$ 26.86
US$ 29.87
US$ 24.83
US$ 23.75
US$ 26.43
US$ 21.84
US$ 29.48
US$ 21.95
US$ 25.70
